Home › Cancer (all types) › NCT03617237
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation at the University of Texas Southwestern Medical Center
Who can join
Ages 18 to 99 · All sexes
Full eligibility criteria
Inclusion Criteria: Any patient who received or was potentially evaluated for radiotherapy since 2000 for benign or malignant etiologies in the definitive or palliative setting. Patients with comparatively similar diagnosis and disease status at UTSW, but electing not to undergo radiation therapy, treated with surgical or systemic therapy, or best supportive care, being followed by an oncology specialist at UT Southwestern Medical Center will also be eligible for evaluation. - Exclusion Criteria: None
About the study
Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies.
To compare the outcomes with National Cancer Data Base (NCDB) of the American College of Surgeon(ACS).
What is being tested
- Retrospective Populations (other)
Sponsor: University of Texas Southwestern Medical Center · Participants: 10,000 · Started: Jul 3, 2012
Contact the study team
- Sarah Neufeld, MS · Phone: 2146458525
- David J Sher, MD, MPH · Phone: 214-645-8525
Official record on ClinicalTrials.gov — NCT03617237
Locations in the U.S.
| Texas | UT Southwestern Medical Centre, Dallas |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.